Strand Life Sciences, a global genomic profiling company that uses next generation sequencing technology to empower cancer care, today announced the appointment of Mr Scott A Storrer as chief executive officer.

Mr Storrer will also be responsible for the continued development and marketing of Strand's precision medicine products in India.

In his expanded role as now president and CEO, he will be responsible for all strategy, business expansion and worldwide operations effective immediately.

Dr Chandru, who has served as Strand's chairman and CEO since its founding in 2000, will continue in his role as chairman of the board of directors.

"Scott's twenty-plus years of executive experience leading and growing profitable businesses in the healthcare industry across the payer, provider and personalized medicine sectors will help Strand develop a strong presence globally," Dr Chandru said.

Mr Storrer will also oversee the continued expansion of Strand Life Sciences' genomics software business.